GRTS - Gritstone Oncology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GRTS is currently covered by 4 analysts with an average price target of $0.89. This is a potential upside of $0.87 (4350%) from yesterday's end of day stock price of $0.02.

Gritstone Oncology's activity chart (see below) currently has 4 price targets and 13 ratings on display. The stock rating distribution of GRTS is 90.91% BUY and 9.09% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.38% with an average time for these price targets to be met of 73.33 days.

Highest price target for GRTS is $4, Lowest price target is $1, average price target is $6.5.

Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 07-Dec-2023. First documented stock forecast 11-Dec-2018.

Best performing analysts who are covering GRTS - Gritstone Oncology:

Thomas Shrader Madhu Kumar Corinne Jenkins Sean Lee Edward Tenthoff Mayank Mamtani

Currently out of the existing stock ratings of GRTS, 10 are a BUY (90.91%), 1 are a SELL (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$4.99 (494.06%)

$8

1 years 8 months 12 days ago
(07-Dec-2023)

0/2 (0%)

$4.38 (270.37%)

Buy

$7

$5.99 (593.07%)

$6

1 years 10 months 22 days ago
(28-Sep-2023)

0/2 (0%)

$5.44 (348.72%)

Buy

$7

$5.99 (593.07%)

$7

2 years 9 days ago
(10-Aug-2023)

1/7 (14.29%)

$5.18 (284.62%)

5

Sell

$2

$0.99 (98.02%)

$15

2 years 11 months 28 days ago
(22-Aug-2022)

1/2 (50%)

$-1.74 (-46.52%)

267

Buy

$35

3 years 10 months 4 days ago
(15-Oct-2021)

0/2 (0%)

$9.45 (36.99%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GRTS (Gritstone Oncology) average time for price targets to be met?

On average it took 73.33 days on average for the stock forecasts to be realized with a an average price target met ratio 27.38

Which analyst has the current highest performing score on GRTS (Gritstone Oncology) with a proven track record?

THOMAS SHRADER

Which analyst has the current lower performing score on GRTS (Gritstone Oncology) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on GRTS (Gritstone Oncology)?

Thomas Shrader works at BTIG and has 10 price targets and 10 ratings on GRTS

Which analyst is the currently most bullish on GRTS (Gritstone Oncology)?

Edward Tenthoff with highest potential upside - $5.99

Which analyst is the currently most reserved on GRTS (Gritstone Oncology)?

Thomas Shrader with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?